2022 07 26 1cannasen registered HK

CANNASEN® is now a registered brand in Hong Kong and New Zeeland

CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the Company has received certificates of registration for trademark CANNASEN® in Hong Kong and New Zealand. This marks an important step for securing the brand in the Company’s expansion on the global market.

CS MEDICA A/S (”CS MEDICA” or the ”Company”) announces today that the trademark offices in New Zealand and Hong Kong have approved CS MEDICA’s trademark CANNASEN®.

“One of the things to secure when building a global business is trademarks. CS MEDICA has always been active in filing patents to secure the future for our products, but we also see the value of securing our brands with trademark registration. This is an additional important step we are taking in our global sales strategy.” says CEO Lone Henriksen.

The trademark approval of CANNASEN® is an important step in CS MEDICA’s market strategy to expand sales of its product line CANNASEN® in the global market. The trademark registration no. for CANNASEN® in New Zeeland is 1440394 and is valid until November 19, 2028. The registration no. for CANNASEN® in Hong Kong is 305799007 and valid until November 10, 2031.

Trademarks as of July 2022;

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@galaxapharma.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.